Navigation Links
Gourmetceuticals Presents Findings on Science You Can Eat at Experimental Biology 2008

Poster presentations highlight findings related to two botanical functional

food ingredients, GLPH-1(TM) and PPL-240(TM)

BIG HORN, Wyo., April 8, 2008 /PRNewswire/ -- Gourmetceuticals, LLC, a company that markets scientifically validated and organically derived ingredients for use in foods and beverages, today announced the findings from four studies that evaluate GLPH-1(TM), an immune booster, and PPL-240(TM), a photoprotective antioxidant, at Experimental Biology 2008 in San Diego. Functional foods are foods and beverages with claimed health benefits based on scientific evidence.

"The functional food market has grown to be a $25 billion industry and consumers should feel confident that the functional ingredients in foods are safe and an effective way to support health and well being," commented Garrett Lindemann, Ph.D., CEO and CSO of Gourmetceuticals. "We are an organization founded on science and are in the early process of transitioning to a commercial organization. It is our commitment to continue ongoing scientific validation of our ingredients."

Both PPL-240 and GLPH-1 have been investigated in more than 20 clinical and pre-clinical studies. The company plans to integrate both ingredients into scientifically validated healthful foods and drinks through strategic co-development deals with key food manufacturers.

PPL-240(TM) -- photoprotective antioxidant

Findings from Polypodium leucotomos extract, PPL-240, prevents solar-induced DNA damage in human peripheral blood mononuclear cells were presented April 6 (poster number: A414) and analyzed the effect of PPL-240 on the cellular damage of human peripheral blood mononuclear cells (PBMC) induced by solar radiation. Cells were incubated for two hours in either presence or absence of PPL-240. The study found that cells in the presence of PPL-240 experienced a reduction in mitogen-induced cell death (18.76% vs. 29.64% respectively).

"We found that PPL-240 reduced cell death caused by sun exposure," commented Dr. Eduardo Reyes, of the Laboratory of Immune System Diseases and Oncology at the National Biotechnology Center Associated Unit Department of Medicine, University of Alcala, Madrid, Spain. "Several previously completed and reported studies of PPL-240 in humans demonstrate its photoprotective properties."

GLPH-1(TM) -- immune booster

Findings from three studies with GLPH-1 were presented on April 8 that evaluated GLPH-1 compared to a common antibiotic, and two on its mechanism of action and pathway.

Experimental animal model study of diet supplementation with phosphorylated alpha glucomannan polysaccharide, GLPH-1 (poster number: C304) evaluated the efficacy of GLPH-1 as an alternative to bacitracin (BMD 60), a common antibiotic, fed to broiler chickens. During the course of 345 days, GLPH-1, fed at 1 mg/kg body weight, was compared to bacitracin at a sub-therapeutic level and an additive free diet in a production setting. Food intake per pen and individual body weights were collected. The study found that GLPH-1 was a growth promoting additive resulting in body weight gain (2.87% and 3.10%) with no associated increase in mortality. However, chickens fed with BMD 60 suffered a reduced accumulated survival and diminished body weight (-3.72% and -4.03%).

"The practice of supplementing animal diets with antibiotics is increasingly problematic as sub-therapeutic doses of antibiotics are linked to antibiotic-resistant strains of bacteria in humans," commented Dr. Lindemann. "The World Health Organization has recommended that antibiotics not be used for growth promotion in feed animals. GLPH-1 may be a safe and effective, natural alternative."

The second study The presence of an alpha glucomannan polysaccharide, GLPH-1, (IF-S) activates NFkB and p38 in hMDDC (poster number: A466) found that GLPH-1 activates white blood cells, an important part of the body's immune system, and that it binds to pathogen receptor sites to reduce uptake of infectious and disease causing agents.

The third study IF-S, a phosphorylated alpha glucomannan polysaccharide, GLPH-1, induces functional human dendritic cell maturation (poster number: A465) found that GLPH-1 may be a useful reagent for regulating immune response against viruses and bacteria.

About Functional Foods

Functional foods are foods and beverages with claimed health benefits based on scientific evidence. The field of functional foods is an emerging field in the food science industry and is composed of the foods that contain scientifically validated ingredients that provide a health benefit above the benefit of the food itself. The market is growing exponentially with a projected growth from $25 billion in 2006 to $39 billion by 2011.

About Gourmetceuticals

Gourmetceuticals, LLC is a research-based culinary technology company that markets organically derived and scientifically tested ingredients for use in foods and beverages. Its ingredients, GLPH-1(TM) and PPL-240(TM), can transform human and veterinary products into gourmet functional foods and are FDA approved for human and animal consumption, GRAS affirmed, Kosher and meet current Good Manufacturing Practices (cGMP) as outlined by the FDA. GLPH-1 is a polysaccharide extract from botanical yeast that promotes immune health and PPL-240 is an antioxidant derived from a South American fern that has been shown clinically to reduce damage from UVA and UVB rays. Both ingredients have been subject to more than 20 clinical trials that evaluated and supported their safety and effectiveness in humans and animals. For more information, visit the Company Web site at

SOURCE Gourmetceuticals, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Gourmetceuticals to Present Data from Four Studies at Experimental Biology 2008
2. Updated GOLD report presents new understandings in diagnosis, treatment and prevention of COPD
3. The Art Of Maternity(TM) at Destination Maternity(R) Presents A Sacred Passage Into Motherhood; the Art of Belly Masking to Belly Casting
4. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
5. VNUS Medical Technologies Presents at William Blair Small-Cap Growth Stock Conference
6. NARSAD - Worlds Leading Mental Health Research Charity - Presents 19th Annual New York Mental Health Symposium, Oct. 19th & 20th
7. Retirement Living TV Presents Sex, Drugs and Rock N Roll
8. AviaraDx Presents at 2007 BIOCOM Investor Conference
9. NARSAD - the Worlds Leading Mental Health Research Charity - Presents 2007 Prizes for Outstanding Psychiatric Research at New York Gala, October 19th
10. California Science Center Science Matters Speakers Program Presents The Science and Ethics of Fear
11. Borgata Heart & Soul Foundation Presents Third Annual Women in Wine Event
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE ... team that developed an innovative way to use nonlinear ... the delivery of new drugs. ... Clinical Dermatology Conference will show how researchers from BioPharmX ... Harvard Medical School used a suite of imaging techniques ...
(Date:10/10/2017)... received FDA 510(k) clearance in May 2017 for its highly anticipated ... for endoscopy environments. An innovative secondary monitor solution, ZeroWire Mobile ... the improvement of patient outcomes, procedural efficiency, and the lowering of ... ... By ...
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare product ... training aide "cprCUBE" on Kickstarter. The device will educate ... cardiac arrests with better efficiency compared to the dated ... real-time feedback on efficacy of the compression for a ... has a goal to raise $5,000. ...
Breaking Medicine Technology: